Influence of new treatment modalities on adherence in glaucoma

Frances Meier-Gibbons, Michael S. Berlin, Marc Töteberg-Harms

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Purpose of reviewIt is well known that glaucoma patients are not adherent to their therapeutic regimens. The issue of nonadherence is multifactorial and includes inadequate communication between doctors and patients, resulting in significant costs associated with enhanced disease progression. Therapeutic regimens are risk factors which often influences adherence rates. Thus, alternative treatment modalities, especially those risk factors that do not rely on patients' cooperation, may enable improvements in long-term outcomes of glaucoma in patient.Recent findingsThe studies selected for this review were divided into new medications, especially advancements in pharmaceutical approaches to treat glaucoma and new ways of delivering the medication, new surgical methods, especially minimally invasive surgery methods for glaucoma, and new studies about adherence in glaucoma.SummarySurprisingly, a very few studies on glaucoma medication or surgery addressed the concept of adherence. However, adherence is discussed in studies which consider psychological aspects of patients or communication issues between doctors and patients. Although these studies were performed in clinical settings, the issue of adherence is not addressed; despite it has significant effect on long-term outpatient care. A combination of both aspects, adherence and miscommunication, should be considered in studies.

Original languageEnglish (US)
Pages (from-to)104-109
Number of pages6
JournalCurrent Opinion in Ophthalmology
Issue number2
StatePublished - Mar 1 2019
Externally publishedYes


  • adherence
  • glaucoma diagnostic
  • glaucoma therapy

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Influence of new treatment modalities on adherence in glaucoma'. Together they form a unique fingerprint.

Cite this